S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Coloplast A/S Stock Forecast, Price & News

-0.32 (-1.92%)
(As of 12/3/2021 03:55 PM ET)
Today's Range
50-Day Range
52-Week Range
39,971 shs
Average Volume
70,319 shs
Market Capitalization
$34.74 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CLPBY News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

Coloplast A/S logo

About Coloplast A/S

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.


Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Expands By 563.2%
November 15, 2021 |  americanbankingnews.com
Coloplast A/S (OTCMKTS:CLPBY) Upgraded at Cheuvreux
November 11, 2021 |  americanbankingnews.com
Coloplast opens new factory in Costa Rica
September 8, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Surgical appliances & supplies
Current Symbol
Previous Symbol
Year Founded

Sales & Book Value

Annual Sales
$2.76 billion
Cash Flow
$0.31 per share
Book Value
$0.48 per share


Net Income
$585.21 million
Pretax Margin




Outstanding Shares
Free Float
Market Cap
$34.74 billion
Not Optionable

Company Calendar

Last Earnings

Social Links


Overall MarketRank

1.55 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Coloplast A/S (OTCMKTS:CLPBY) Frequently Asked Questions

Is Coloplast A/S a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Coloplast A/S in the last year. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Coloplast A/S stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLPBY, but not buy additional shares or sell existing shares.
View analyst ratings for Coloplast A/S
or view top-rated stocks.

How has Coloplast A/S's stock been impacted by Coronavirus?

Coloplast A/S's stock was trading at $13.5590 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CLPBY stock has increased by 18.6% and is now trading at $16.0850.
View which stocks have been most impacted by COVID-19

Are investors shorting Coloplast A/S?

Coloplast A/S saw a increase in short interest in the month of October. As of October 29th, there was short interest totaling 25,200 shares, an increase of 563.2% from the October 14th total of 3,800 shares. Based on an average trading volume of 75,300 shares, the days-to-cover ratio is currently 0.3 days.
View Coloplast A/S's Short Interest

How were Coloplast A/S's earnings last quarter?

Coloplast A/S (OTCMKTS:CLPBY) posted its quarterly earnings data on Thursday, May, 2nd. The company reported $0.07 earnings per share for the quarter, hitting analysts' consensus estimates of $0.07. The business earned $688.45 million during the quarter. Coloplast A/S had a net margin of 21.62% and a trailing twelve-month return on equity of 69.30%.
View Coloplast A/S's earnings history

How often does Coloplast A/S pay dividends? What is the dividend yield for Coloplast A/S?

Coloplast A/S declared a dividend on Friday, May 14th. Stockholders of record on Monday, May 17th will be given a dividend of $0.3652 per share on Monday, May 24th. This represents a dividend yield of 2.34%. The ex-dividend date of this dividend is Friday, May 14th. This is a boost from Coloplast A/S's previous dividend of $0.28.
View Coloplast A/S's dividend history

Is Coloplast A/S a good dividend stock?

Coloplast A/S pays an annual dividend of $0.22 per share and currently has a dividend yield of 1.47%. The dividend payout ratio of Coloplast A/S is 73.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Coloplast A/S will have a dividend payout ratio of 61.11% next year. This indicates that Coloplast A/S will be able to sustain or increase its dividend.
View Coloplast A/S's dividend history.

What guidance has Coloplast A/S issued on next quarter's earnings?

Coloplast A/S updated its FY 2022 earnings guidance on Monday, November, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.33 billion-$3.33 billion.

Who are Coloplast A/S's key executives?

Coloplast A/S's management team includes the following people:
  • Kristian Villumsen, President & Chief Executive Officer
  • Allan Rasmussen, Executive Vice President-Global Operations
  • Anders Lonning-Skovgaard, Chief Financial Officer & Executive Vice President
  • Oliver Johansen, Senior VP-Global Research & Development
  • Thomas Barfod, Director & Controller

What is Coloplast A/S's stock symbol?

Coloplast A/S trades on the OTCMKTS under the ticker symbol "CLPBY."

How do I buy shares of Coloplast A/S?

Shares of CLPBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Coloplast A/S's stock price today?

One share of CLPBY stock can currently be purchased for approximately $16.09.

How much money does Coloplast A/S make?

Coloplast A/S has a market capitalization of $34.74 billion and generates $2.76 billion in revenue each year. The company earns $585.21 million in net income (profit) each year or $0.30 on an earnings per share basis.

How many employees does Coloplast A/S have?

Coloplast A/S employs 12,500 workers across the globe.

When was Coloplast A/S founded?

Coloplast A/S was founded in 1954.

What is Coloplast A/S's official website?

The official website for Coloplast A/S is www.coloplast.com.

Where are Coloplast A/S's headquarters?

Coloplast A/S is headquartered at HOLTEDAM 1-3, HUMLEBAEK G7, 3050.

How can I contact Coloplast A/S?

Coloplast A/S's mailing address is HOLTEDAM 1-3, HUMLEBAEK G7, 3050. The company can be reached via phone at (454) 911-1111 or via email at [email protected].

This page was last updated on 12/4/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.